Outcome of Hyperthyroidism Therapy by Radioactive Iodine (I-131) Using a Fixed Dose in Combination with a Radioactive Iodine Uptake


  • Krisana Roysri Department of Radiology, Surin Hospital, Surin Province, Thailand


hyperthyroid, radioactive I-131, radioactive iodine uptake


Background and Objective: The treatment of thyroid toxicity using iodine-131 (I-131) radioiodine therapy is an efficient and economically viable approach for patient care. The adjustment of radiation dosage for patients depends on the specific abnormalities of their thyroid glands. The study aimed to investigate outcomes of treating thyroid toxicity with I-131 at Surin Hospital, emphasizing the significance of optimizing radiation dosage for effective and economical patient care.

Methods: This study was descriptive retrospectively analyzed 195 hyperthyroid patients treated with radioactive iodine treatment (RAIT); 183 of whom underwent radioactive iodine uptake test (RAIU).

Results: At a first year, the remission rate was 78.14% (p < 0.001). The mean ± SD dose of I-131 was 20.36 ± 5.74 mCi. Age, sex, and RAIU were not associated with the remission (p > 0.05). However, males tended to have a lower remission rate than females (p = 0.07). In one patient, the results of the RAIU changed the diagnosis to thyroiditis, thus avoiding unnecessary RAIT.

Conclusions: The treatment for hyperthyroidism at Surin Hospital has a high success rate during the first year. This is because the amount of radiation used is quite high and measuring the amount of radiation on the neck helps in diagnosing patients with thyroiditis. This prevents patients from being exposed to unnecessary radiation.


Wan Mohamed WMI, Sayuti SC, Draman N. Hypothyroidism and its associated factors after radioactive iodine therapy among patients with hyperthyroidism in the Northeast Coast State of Malaysia. J Taibah Univ Med Sci 2018;13(5):432–7. doi: 10.1016/j.jtumed.2018.06.004.

Galman D. Simulations and measurements of radiation doses from patients treated with I-131 [Internet]. 2018 [cited 2023 May 20]. Available from: https://umu.diva-portal.org/smash/get/ diva2:1201834/FULLTEXT01.pdf

Mengistu HS, Getahun KT, Alemayehu L, Gezahign S. Cost-Effectiveness analysis of antithyroid drug (propylthiouracil) compared to radioactive iodine for the treatment of graves; disease in Ethiopia. Clin Outcomes Res 2022;14:221–9. doi: 10.2147/ CEOR.S350984.

Xing YZ, Zhang K, Jin G. Predictive factors for the outcomes of graves’ disease patients with radioactive iodine (131I) treatment. Biosci Rep 2020;40(1):BSR20191609. doi: 10.1042/BSR 20191609.

Kiatkittikul P, Raruenrom Y, Theerakulpisut D, Somboonporn C. Success rate of radioactive iodine therapy in graves’ disease using dose corrected for thyroid gland size. Siriraj Med J 2021;73(2):108–13. doi: 10.33192/Smj.2021.15.

Isah AR, Kotze T. Efficacy of single fixed dose of radioiodine (I 131) therapy in patients treated for hyperthyroidism at Nuclear Medicine Department of Groote Schuur Hospital(GSH). West Afr J Med 2020;37(4):349–54. doi: 10.14740/jem.v13i2.874.

Kuanrakcharoen P. Radioiodine (I-131) dose for the treatment of hyperthyroidism in Rajavithi Hospital. J Med Assoc Thai 2016;99 (Suppl 2):S123–9.

Ghahremani GG, Hoffer PB, Oppenheim BE, Gottschalk A. New normal values for thyroid uptake of radioactive iodine. JAMA 1971;217(3):337. doi:10.1001/jama.1971.03190030061017

Younis J. Role of radioactive iodine-131 in management of hyperthyroid patients seen at Nemrock: a local experience study. Egypt J Nucl Med 2013;7(7):55–63. doi: 10.21608/egyjnm. 2013.5468.

Al-Qahtani SM, Al-osaimi MB, Abdelalim M, Althomali MA, Alomari AH, Bawazeer OA, et al. Evaluating the effectiveness of a fixed little dose of radioactive iodine (I-131) in treatment for Graves’ disease. J Radiat Res Appl Sci 2023; 16(3):100633. doi:10.1016/j.jrras.2023.100633.

Coşkun N, Özdemir E. Predictors of early-onset overt hypothyroidism in hyperthyroid patients treated with radioiodine. Ank Med J 2022;22(4): 556–66. doi: 10.5505/amj.2022.58159.

Ballal S, Soundararajan R, Bal C. Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population. Indian J Med Res 2017;145(3): 358–64. doi: 10.4103/ijmr.IJMR_1158_14.

Altoos R, Altoos B, Kreidler S, Bagrosky B, Koo P, Kwak J. Risk factors for recurrence of hyperthy¬roidism after I-131 radioiodine therapy. J Nucl Med 2015;56(suppl 3):669. doi: 0161-5505, 2159-662X.



How to Cite

Roysri K. Outcome of Hyperthyroidism Therapy by Radioactive Iodine (I-131) Using a Fixed Dose in Combination with a Radioactive Iodine Uptake . SRIMEDJ [Internet]. 2024 Apr. 24 [cited 2024 Jun. 19];39(2):178-83. Available from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/261263



Original Articles